Skip to main content
SpringerLink
Log in

Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The tumor suppressor PTEN gene maps to chromosome 10q23.3 and encodes a dual specificity phosphatase. Mutations of this gene had been found in a variety of human tumors. In the present study, we analyzed the structure and expression of the PTEN gene in 34 hepatocellular carcinoma tissues and two hepatoma cell lines. We found neither homozygous nor hemizygous deletions in these samples. We, however, found point mutations in 4 of the 34 tissue samples. Five of ten hepatocellular carcinoma tissues showed reduced PTEN expression at mRNA level. HepG2 and SMMC-7721 hepatoma cells showed decreased PTEN expression at both mRNA and protein levels compared with immortalized L02 hepatic cells. PTEN mRNA in SMMC-7721 hepatoma cells could be reduced by TGF-βI treatment. We also found that the phosphorylation levels of FAK in both of the hepatoma cell lines were higher than that in L02 hepatic cells. Transient expression of the PTEN gene in SMMC-7721 and HepG2 hepatoma cells resulted in decreased FAK phosphorylation. The level of FAK tyrosine phosphorylation appeared to be inversely correlated with the level of the PTEN protein. In summary, our results indicated that the function of the PTEN gene in hepatocarcinomas may be impaired mainly through point mutations and expression deficiency and that the defect of PTEN in tumor cells could alter the phosphorylation of FAK. (Mol Cell Biochem 262: 25–33, 2004)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, TyckoB, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–1947, 1997

    Article  PubMed  Google Scholar 

  2. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV: Identification of a candidate tumour suppressor gene,MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356–362, 1997

    Article  PubMed  Google Scholar 

  3. Olschwang S, Serova-Sinilnikova OM, Lenoir GM, Thomas G: PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 18: 12–14, 1998

    Article  PubMed  Google Scholar 

  4. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64–67, 1997

    Article  PubMed  Google Scholar 

  5. Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16: 333–334, 1997

    Article  PubMed  Google Scholar 

  6. Chiariello E, Roz L, Albarosa R, Magnani I, Finocchiaro G: PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene 16: 541–545, 1998

    Article  PubMed  Google Scholar 

  7. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183–4186, 1997

    PubMed  Google Scholar 

  8. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660–3663, 1997

    PubMed  Google Scholar 

  9. Risinger JI, Hayes AK, Berchuck A, Barrett JC: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57: 4736–4738, 1997

    PubMed  Google Scholar 

  10. Butler MP, Wang SI, Chaganti RS, Parsons R, Dalla-Favera R: Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. Genes Chromosomes Cancer 24: 322–327, 1999

    Article  PubMed  Google Scholar 

  11. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL: Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95: 5246–5250, 1998

    PubMed  Google Scholar 

  12. Yokomizo A, Tindall DJ, Drabkin H, Gemmill R, Franklin W, Yang P, Sugio K, Smith DI, Liu W: PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 17: 475–479, 1998

    PubMed  Google Scholar 

  13. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR: Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 59: 4291–4296, 1999

    PubMed  Google Scholar 

  14. Yaginuma Y, Yamashita T, Ishiya T, Morizaki A, Katoh Y, Takahashi T, Hayashi H, Ishikawa M: Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers. Mol Carcinog 27: 110–116, 2000

    Article  PubMed  Google Scholar 

  15. Kang YH, Lee HS, Kim WH: Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest 82: 285–291, 2002

    PubMed  Google Scholar 

  16. Tang ZY: Hepatocellular carcinoma–cause, treatment and metastasis. World J Gastroenterol 7: 445–454, 2001

    PubMed  Google Scholar 

  17. Wild CP, Hall AJ: Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res 462: 381–393, 2000

    Article  PubMed  Google Scholar 

  18. Biden K, Young J, Buttenshaw R, Searle J, Cooksley G, Xu DB, Leggett B: Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population. Hepatology 25: 593–597, 1997

    Article  PubMed  Google Scholar 

  19. Qin G, Su J, Ning Y, Duan X, Luo D, Lotlikar PD: p53 protein expression in patients with hepatocellular carcinoma from the high incidence area of Guangxi, Southern China. Cancer Lett 121: 203–210, 1997

    Article  PubMed  Google Scholar 

  20. Fujiwara Y, Hoon DS, Yamada T, Umeshita K, Gotoh M, Sakon M, Nishisho I, Monden M: PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res 91: 287–292, 2000

    PubMed  Google Scholar 

  21. Piao Z, Park C, Park JH, Kim H: Allelotype analysis of hepatocellular carcinoma. Int J Cancer 75: 29–33, 1998

    Article  PubMed  Google Scholar 

  22. Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, PeacockeM, Santella RM, Tsou HC: PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 18: 3181–3185, 1999

    Article  PubMed  Google Scholar 

  23. Mathew CG, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BA: Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328: 524–526, 1987

    Article  PubMed  Google Scholar 

  24. Spinardi L, Mazars R, Theillet C: Protocols for an improved detection of point mutations by SSCP. Nucleic Acids Res 19: 4009, 1991

    PubMed  Google Scholar 

  25. De Nichilo MO, Yamada KM: Integrin alpha v beta 5-dependent serine phosphorylation of paxillin in cultured human macrophages adherent to vitronectin. J Biol Chem 271: 11016–11022, 1996

    Article  PubMed  Google Scholar 

  26. Sacco R, Leuci D, Tortorella C, Fiore G, Marinosci F, Schiraldi O, Antonaci S: Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. Cytokine 12: 811–814, 2000

    Article  PubMed  Google Scholar 

  27. Tsai JF, Jeng JE, Chuang LY, Yang ML, HoMS, Chang WY, Hsieh MY, Lin ZY, Tsai JH: Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma. Br J Cancer 75: 1460–1466, 1997

    PubMed  Google Scholar 

  28. Giancotti FG, Ruoslahti E: Integrin signaling. Science 285: 1028–1032, 1999

    Article  PubMed  Google Scholar 

  29. Schlaepfer DD, Hunter T: Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol 8: 151–157, 1998

    Article  PubMed  Google Scholar 

  30. Tamura M, Gu J, Danen EH, Takino T, Miyamoto S, Yamada KM: PTEN interactions with focal adhesion kinase and suppression of the 33 extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 274: 20693–20703, 1999

    Article  PubMed  Google Scholar 

  31. Georgescu MM, Kirsch KH, Kaloudis P, Yang H, Pavletich NP, Hanafusa H: Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60: 7033–7038, 2000

    PubMed  Google Scholar 

  32. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, Pavletich NP: Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: 323–334, 1999

    PubMed  Google Scholar 

  33. Yeh KT, Chang JG, Chen YJ, Chen ST, Yu SY, Shih MC, Perng LI, Wang JC, Tsai M, Chang CP: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma. Cancer Invest 18: 123–129, 2000

    PubMed  Google Scholar 

  34. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997–5000, 1997

    PubMed  Google Scholar 

  35. Ebert MP, Fei G, Schandl L, Mawrin C, Dietzmann K, Herrera P, Friess H, Gress TM, Malfertheiner P: Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1. Br J Cancer 86: 257–262, 2002

    Article  PubMed  Google Scholar 

  36. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK: The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: 13513–13518, 1998

    Article  PubMed  Google Scholar 

  37. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL: The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95: 15587–15591, 1998

    Article  PubMed  Google Scholar 

  38. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614–1617, 1998

    Article  PubMed  Google Scholar 

  39. Cary LA, Han DC, Polte TR, Hanks SK, Guan JL: Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J Cell Biol 140: 211–221, 1998

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai, P. R, China

    Lineng Zhang, Jianyu He & Xiliang Zha

  2. Department of Biochemistry, Tongji University School of Medicine, Shanghai, P. R, China

    Lineng Zhang

  3. The Pulmonary Center and Department of Biochemistry, Boston University, Medical Center, Boston, MA, USA

    Qiang Yu

Authors
  1. Lineng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jianyu He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiliang Zha
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, L., Yu, Q., He, J. et al. Study of the PTEN gene expression and FAK phosphorylation in human hepatocarcinoma tissues and cell lines. Mol Cell Biochem 262, 25–33 (2004). https://doi.org/10.1023/B:MCBI.0000038212.78008.7f

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000038212.78008.7f

Search

Navigation